文献速递神经肿瘤

弥漫性低级别胶质瘤地图引导术后15年以上幸存者的功能状态:103例连续病例分析

Functional status in long-term survivors after mapping-guided surgery for diffuse low-grade glioma: a consecutive series of 103 patients with a postoperative follow-up of at least 15 years.
PubMed 文献 · J Neurosurg · 2025-09-12

该研究纳入103例接受术中地图引导切除的弥漫性低级别胶质瘤患者,随访至少15年(平均18.2年),总生存率83.5%。末次评估时存活者中90.7%的KPS评分≥80,81例(90%)能够重返工作。早期放疗与较低的重返工作率相关(p=0.05),且放疗患者末次随访KPS≥80的比例更低(p=0.005)。

要点

  • 地图引导切除后长期幸存者功能状态保留良好,90.7%存活者KPS≥80。
  • 早期放疗与较低重返工作率及末次KPS≥80比例较低相关。
  • 术前和术后肿瘤体积较小及切除程度更高者更可能维持工作。

核心结论

  • 地图引导手术治疗弥漫性低级别胶质瘤后,患者长期功能状态包括职业活动得以保留,尤其在接受早期超全/全切除且未接受放疗的患者中。

研究设计与样本

  • 连续队列研究,纳入103例接受术中地图引导切除且术后随访≥15年的弥漫性低级别胶质瘤患者,比较术后持续工作至末次随访组与未重返工作或因病停止工作组。

主要发现

  • 平均随访18.2±2.9年,总生存率83.5%;末次评估时86例存活者中78例(90.7%)KPS≥80。
  • 81例(90%)能够重返工作;术后平均KPS为94.8±5.7。
  • 早期放疗与较低的重返工作率相关(p=0.05),放疗患者末次随访KPS≥80比例更低(p=0.005)。
  • 未重返工作组术前(p=0.003)和术后3个月(p<0.00001)平均KPS更低;持续工作组术前(p=0.046)和术后(p=0.047)肿瘤体积更小,切除程度更高(p=0.03)。

关键数值与推荐

  • 纳入标准:低级别胶质瘤患者,由作者行术中地图引导手术,术后随访≥15年。
  • 功能评估采用Karnofsky功能状态评分(KPS)和职业活动状态。

临床怎么用

  • 对于弥漫性低级别胶质瘤,应追求早期超全/全切除以利于长期功能状态和职业活动的保留。
  • 早期放疗可能与较低的重返工作率和长期KPS≥80比例较低相关,决策时需权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite a current overall survival (OS) > 20 years in patients undergoing surgery for diffuse low-grade glioma (LGG), there is no study focusing on functional status in long-term survivors. Here, a unique cohort of LGG patients followed for at least 15 years after mapping-guided resection is reported with analysis of long-lasting outcomes, especially the ability to work. METHODS: Inclusion criteria were LGG patients operated on by the author using intraoperative mapping and follow-up ≥ 15 years after surgery. Long-term functional results were studied by assessing the Karnofsky Performance Scale (KPS) score and professional activity until the last evaluation. Two groups were compared: group 1 comprising patients who continued to work after surgery until the last follow-up, including those who eventually retired because of age; and group 2 comprising patients who did not return to work (RTW) after surgery or who stopped working because of their disease during follow-up. RESULTS: This consecutive cohort included 103 patients (54 men [52.4%], 49 women [47.6%], mean ± SD age 37.8 ± 7.6 years), including 96 (93.2%) who experienced seizures (and 7 with incidentalomas [6.8%]). The mean preoperative tumor volume was 46.7 ± 35.6 cm3. Three patients (2.9%) had postoperative hemianopia deliberately generated. The mean postoperative KPS score was 94.8 ± 5.7, with 81 patients able to RTW (90%). The mean extent of resection (EOR) was 93.4% ± 7.4%, with 40 supratotal/total resections (38.8%). The mean residual tumor volume was 3.6 ± 5.6 cm3. There were 22 isocitrate dehydrogenase-mutated astrocytomas (21.4%) and 48 oligodendrogliomas (46.6%) (33 gliomas not otherwise specified [32%]). Ten patients (9.7%) received early radiotherapy, which was correlated to a lower rate of RTW (p = 0.05). Sixty-three patients (61.2%) underwent reoperation(s), with a total rate of neurological morbidity of 1.5% after 205 resections. The mean follow-up was 18.2 ± 2.9 years with an OS rate of 83.5%. Among the 86 patients who were still alive at final evaluation, 78 (90.7%) had KPS score ≥ 80. The proportion of patients with KPS score ≥ 80 at last follow-up was lower among irradiated patients (p = 0.005). The mean KPS score was lower before (p = 0.003) and 3 months after (p < 0.00001) surgery in group 2. In group 1, the preoperative (p = 0.046) and postoperative (p = 0.047) tumor volumes were smaller, with greater extent of resection (p = 0.03). CONCLUSIONS: This is the first series of LGG patients who lived ≥ 15 years after mapping-based surgery. These original data show long-term preservation of functional status, including professional activities, particularly in patients with early supratotal/total resection and without radiation therapy.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Duffau H. Functional status in long-term survivors after mapping-guided surgery for diffuse low-grade glioma: a consecutive series of 103 patients with a postoperative follow-up of at least 15 years. J Neurosurg. 2025. PMID: 40939215. doi:10.3171/2025.5.JNS25819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。